Observational, Multicenter study on long-term Effectiveness and tolerability of aliROcumab (OMERO): an Italian real-life experience

20250 citationsJournal Articlegold Open Access

Authors

Alberico L. Catapano · University of Milan

Aldo P. Maggioni · Associazione Nazionale Medici Cardiologi Ospedalieri

Francesco Rossi · University of Campania "Luigi Vanvitelli"

Eleonora Consolo · Sanofi (Italy)

Lucia Notarianni · Sanofi (Italy)

Giancarlo Agnelli · University of Perugia

Abstract

The effectiveness of alirocumab in reducing LDL-C and its favorable safety and tolerability profile have been consistently confirmed in a real-world setting among Italian patients treated for up to 3 years.

Topics & Keywords

Lipoproteins and Cardiovascular Health Atherosclerosis and Cardiovascular Diseases Diabetes Treatment and Management

Publication Details

Published in: International Journal of Cardiology Cardiovascular Risk and Prevention

Volume 28, pp. 200549-200549

DOI: 10.1016/j.ijcrp.2025.200549

Field-Weighted Citation Impact: 0.00

Command Palette

Observational, Multicenter study on long-term Effectiveness and tolerability of aliROcumab (OMERO): an Italian real-life experience

Authors

Abstract

Topics & Keywords

Publication Details